Àá½Ã¸¸ ±â´Ù·Á ÁÖ¼¼¿ä. ·ÎµùÁßÀÔ´Ï´Ù.
KMID : 0359020100400030175
Korean Journal of Gastrointestinal Endoscopy
2010 Volume.40 No. 3 p.175 ~ p.180
Two Cases of Gastric Marginal Zone B Cell Lymphoma Treated with a Single Agent Chemotherapy
Bae Young Seok

Lee Kwang-Jae
Kim Dong-Wan
Hong Jun-Ho
Yoon Jung-Bin
Bae Sang-Hoon
Lee Jin-Sook
Song Chul-Soo
Abstract
Gastric marginal zone B cell lymphoma of the MALT type (MALT lymphoma) is usually accompanied by a Helicobacter pylori (H. pylori) infection. Most gastric MALT lymphomas regress after the eradication of H. pylori. Therefore, H. pylori eradication therapy is an effective first-line treatment for gastric MALT lymphoma. A second-line treatment for patients who fail to respond to eradication therapy, including radiotherapy and chemotherapy, produces a good response and survival rate. We encountered 2 cases of H. pylori eradication-resistant gastric MALT lymphoma, which were treated with cyclophosphamide monotherapy. A complete response was obtained in both cases after a treatment duration of 3 months and remission continued for 15 and 18 months, respectively. Treatment-related toxicity was mild. Oral monochemotherapy might be an alternative, effective and safe treatment modality for patients with gastric MALT lymphoma who are resistant to H. pylori eradication therapy.
KEYWORD
Stomach, Marginal zone, MALT, Cyclophosphamide
FullTexts / Linksout information
 
Listed journal information
ÇмúÁøÈïÀç´Ü(KCI) KoreaMed ´ëÇÑÀÇÇÐȸ ȸ¿ø